20 (AIDX) Receivables (2024 - 2026)

20 (AIDX) posted Receivables of $201481.0 for Q1 2026, up 0.76% on a QoQ basis from $199954.0 in Q4 2025.

20 (AIDX) Receivables (2024 - 2026) Analysis & Trends

20's Receivables history runs 3 years deep, the most recent figure standing at $201481.0 for Q1 2026.

Quarterly Receivables changed N/A year-over-year to $201481.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $201481.0 (changed N/A YoY) and the FY2025 annual result came in at $199954.0, up 47.82% from the prior year.
Receivables was $201481.0 for Q1 2026 at 20, up from $199954.0 in the prior quarter.
Across five years, Receivables topped out at $201481.0 in Q1 2026 and bottomed at $135272.0 in Q4 2024.
A 3-year average of $178902.3 and a median of $199954.0 in 2025 frame the typical range for Receivables.
Peak annual rise in Receivables reached 47.82% in 2025, while the deepest fall reached 47.82% in 2025.
20's Receivables stood at $135272.0 in 2024, then jumped by 47.82% to $199954.0 in 2025, then climbed by 0.76% to $201481.0 in 2026.
Business Quant data shows AIDX's Receivables at $201481.0 in Q1 2026, $199954.0 in Q4 2025, and $135272.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	8.21 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	3.57 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	6.64 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	3.03 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	973.00 Mn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	1.11 Bn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	3.80 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	4.50 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	1.55 Bn
10	20	3.91 Mn	-313,912.28	62,884.00	201,481.00

Download Data